Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study
ObjectiveTo evaluate gender-specific variations in cardiovascular disease (CVD) risk stratification and its modifiable determinants among individuals concurrently diagnosed with type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH).MethodsA cross-sectional observational study was cond...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1635444/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849728347431501824 |
|---|---|
| author | Xiang Zhao Ke He Ji Li Lingyan Zhou Ling Liu Xiwan Lu Yan Jiang |
| author_facet | Xiang Zhao Ke He Ji Li Lingyan Zhou Ling Liu Xiwan Lu Yan Jiang |
| author_sort | Xiang Zhao |
| collection | DOAJ |
| description | ObjectiveTo evaluate gender-specific variations in cardiovascular disease (CVD) risk stratification and its modifiable determinants among individuals concurrently diagnosed with type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH).MethodsA cross-sectional observational study was conducted involving 2,357 patients with T2DM (1,120 males and 1,237 females) who were hospitalized at Wuxi Hospital of Traditional Chinese Medicine between 2018 and 2024. Participants were categorized into the SCH (n=196) and the euthyroid subgroups (n=2,161). The 10-year probability of cardiovascular events was estimated based on the Framingham Risk Score (FRS) model. Sex-specific differences in SCH prevalence and CVD risk were examined, and associations between FRS and biomarkers—namely thyroid-stimulating hormone (TSH), free thyroxine (FT4), cystatin C (CysC) and other factors—were analyzed via Spearman’s correlation analysis and multivariable linear regression.ResultsThe prevalence of SCH in T2DM patients was 9.06% (10.02% in females vs. 6.43% in males). Male patients diagnosed with SCH exhibited an elevated FRS compared to their euthyroid counterparts (21.00 vs. 20.00, P= 0.025). Within this subgroup, a positive relationship was identified between TSH levels and FRS(r=0.374, P= 0.001), whereas FT4 showed a negative association (r=-0.342, P= 0.003). These relationships were not statistically significant among women diagnosed with SCH. Cystatin C was positively associated with FRS in both male (r=0.461, P<0.001) and female (r=0.452, P<0.001) groups. Multivariable linear regression evaluation in male patients revealed that TSH (β=3.87, P= 0.048), cystatin C (β=1.48, P= 0.03), and FT4 (β=-0.61, P= 0.011) continued to be significantly correlated with 10-year CVD risk. Additionally, male patients with SCH exhibited significantly higher smoking status, uric acid, and creatinine levels than their female counterparts (all P<0.05), indicating that sex-specific risk factors may contribute to elevated CVD risk.ConclusionThis study identified higher FRS in male versus female patients with comorbid T2DM and SCH, potentially mediated by sex-specific variations in TSH, FT4, and CysC levels. These results underscore the importance of implementing sex-specific strategies for CVD risk management in this population. |
| format | Article |
| id | doaj-art-e90e00e4ce534d2787df479fcf59d6d6 |
| institution | DOAJ |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-e90e00e4ce534d2787df479fcf59d6d62025-08-20T03:09:34ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-07-011610.3389/fendo.2025.16354441635444Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional studyXiang Zhao0Ke He1Ji Li2Lingyan Zhou3Ling Liu4Xiwan Lu5Yan Jiang6Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Endocrinology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, ChinaDepartment of Graduate School, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Endocrinology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, ChinaDepartment of Endocrinology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, ChinaDepartment of Endocrinology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, ChinaDepartment of Endocrinology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, ChinaObjectiveTo evaluate gender-specific variations in cardiovascular disease (CVD) risk stratification and its modifiable determinants among individuals concurrently diagnosed with type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH).MethodsA cross-sectional observational study was conducted involving 2,357 patients with T2DM (1,120 males and 1,237 females) who were hospitalized at Wuxi Hospital of Traditional Chinese Medicine between 2018 and 2024. Participants were categorized into the SCH (n=196) and the euthyroid subgroups (n=2,161). The 10-year probability of cardiovascular events was estimated based on the Framingham Risk Score (FRS) model. Sex-specific differences in SCH prevalence and CVD risk were examined, and associations between FRS and biomarkers—namely thyroid-stimulating hormone (TSH), free thyroxine (FT4), cystatin C (CysC) and other factors—were analyzed via Spearman’s correlation analysis and multivariable linear regression.ResultsThe prevalence of SCH in T2DM patients was 9.06% (10.02% in females vs. 6.43% in males). Male patients diagnosed with SCH exhibited an elevated FRS compared to their euthyroid counterparts (21.00 vs. 20.00, P= 0.025). Within this subgroup, a positive relationship was identified between TSH levels and FRS(r=0.374, P= 0.001), whereas FT4 showed a negative association (r=-0.342, P= 0.003). These relationships were not statistically significant among women diagnosed with SCH. Cystatin C was positively associated with FRS in both male (r=0.461, P<0.001) and female (r=0.452, P<0.001) groups. Multivariable linear regression evaluation in male patients revealed that TSH (β=3.87, P= 0.048), cystatin C (β=1.48, P= 0.03), and FT4 (β=-0.61, P= 0.011) continued to be significantly correlated with 10-year CVD risk. Additionally, male patients with SCH exhibited significantly higher smoking status, uric acid, and creatinine levels than their female counterparts (all P<0.05), indicating that sex-specific risk factors may contribute to elevated CVD risk.ConclusionThis study identified higher FRS in male versus female patients with comorbid T2DM and SCH, potentially mediated by sex-specific variations in TSH, FT4, and CysC levels. These results underscore the importance of implementing sex-specific strategies for CVD risk management in this population.https://www.frontiersin.org/articles/10.3389/fendo.2025.1635444/fullsubclinical hypothyroidismtype 2 diabetes mellituscardiovascular disease risksex differencescomorbidity |
| spellingShingle | Xiang Zhao Ke He Ji Li Lingyan Zhou Ling Liu Xiwan Lu Yan Jiang Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study Frontiers in Endocrinology subclinical hypothyroidism type 2 diabetes mellitus cardiovascular disease risk sex differences comorbidity |
| title | Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study |
| title_full | Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study |
| title_fullStr | Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study |
| title_full_unstemmed | Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study |
| title_short | Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study |
| title_sort | sex differences in 10 year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism a cross sectional study |
| topic | subclinical hypothyroidism type 2 diabetes mellitus cardiovascular disease risk sex differences comorbidity |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1635444/full |
| work_keys_str_mv | AT xiangzhao sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy AT kehe sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy AT jili sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy AT lingyanzhou sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy AT lingliu sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy AT xiwanlu sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy AT yanjiang sexdifferencesin10yearcardiovascularriskofpatientswithtype2diabetesmellitusandsubclinicalhypothyroidismacrosssectionalstudy |